Revolutionizing Early Detection: AI for Pancreatic Cancer Screening


PancMD is on the leading edge of harnessing the power of artificial intelligence to detect pancreatic cancer before it turns deadly.




Pancreatic Cancer: A Critical Need for Early Detection

Pancreatic cancer is one of the most lethal forms of cancer, with a five-year survival rate of less than 10%. Early detection can drastically improve patient outcomes, but current screening methods are limited.
PancMD’s AI-powered technology offers a revolutionary solution, designed to detect the disease in its early stages, when treatment is most effective.


An AI Early Detection Tool to Fight Cancer

PancMD is pioneering the use of artificial intelligence (AI) to identify subtle patterns and early indicators that traditional methods often miss.
Our proprietary algorithms analyze vast amounts of data from CT scans and medical data to pinpoint elevated risk factors in diabetes patients.
PancMD’s innovative application will empower healthcare providers with data-driven diagnostics, enabling earlier interventions to save lives.

Partnering to Save Lives:
Collaboration Opportunities for Healthcare Leaders

PancMD is seeking collaboration with visionary hospitals, research institutions, and healthcare networks to conduct clinical trials, share anonymized data, and validate our AI solutions in real-world settings.
Our healthcare partners will be at the forefront of revolutionizing cancer detection technology, helping us to bring this life-changing diagnostic methodology to the world.

Data Requests for Research

Securely share anonymized data to exponentially improve our AI models and aid in early detection research

Clinical Trials Participation

Join ground-breaking clinical trials that contribute to advancing early cancer detection technologies.


Invest in the Future of Healthcare Innovation

PancMD is at the intersection of pioneering AI technology and diagnostics for pancreatic cancer, one of the most challenging to diagnose and one of the most lethal. Our technology is ambitious and game-changing, with global market potential.

Investors who join our mission have the opportunity to advance a solution that will save lives and transform the landscape of cancer detection and treatment.

Investor Highlights
  • High-Growth Market Potential
  • Proven Technology with Successful Clinical Trials
  • Strong Partnerships with Healthcare Providers and Research Institutions
  • Experienced Leadership Team in AI and Oncology



Industry News

No news available at the moment.

Industry News

News Image 1

PROVIDERS | 3 HOURS AGO

Habitat Health gets $50 million in funding, names CEO

Habitat Health said Tuesday $50 million in capital will help launch PACE programs in California, with the first set to open in Sacramento early next year.

News Image 2

DIGITAL HEALTH | 7 HOURS AGO

Where AI in healthcare is receiving venture capital investment

Venture capital firm Flare Capital analyzed more than 4,000 healthcare AI venture capital deals.